Source: ClinicaSpace

RMI: Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron 1Xi Minute Ventilation Monitor in Pediatric Patients

The ExSpiron is the first and only MV monitor capable of providing continuous, non-invasive measurements for individuals not on a ventilator.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Alexander Panasyuk's photo - Co-Founder of Respiratory Motion

Co-Founder

Alexander Panasyuk

CEO Approval Rating

82/100

Read more